Global Zika Virus Testing Market Analysis and Forecast 2024-2030

Global Zika Virus Testing Market Analysis and Forecast 2024-2030


Summary

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

According to APO Research, The global Zika Virus Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Zika Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Zika Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Zika Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Zika Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Zika Virus Testing include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex, Simens, Abbott Molecular, Hologic, ELITech Molecular Diagnostics and EUROIMMUN US, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Zika Virus Testing, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Zika Virus Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Zika Virus Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Virus Testing revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Zika Virus Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Zika Virus Testing revenue, projected growth trends, production technology, application and end-user industry.

Zika Virus Testing segment by Company

Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics
Zika Virus Testing segment by Type

Molecular Test
Serologic Test
Zika Virus Testing segment by Application

Diagnostic Centers
Hospitals
Pathology Labs
Zika Virus Testing segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Zika Virus Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Zika Virus Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zika Virus Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Zika Virus Testing Market by Type
1.2.1 Global Zika Virus Testing Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Molecular Test
1.2.3 Serologic Test
1.3 Zika Virus Testing Market by Application
1.3.1 Global Zika Virus Testing Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Pathology Labs
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Zika Virus Testing Market Dynamics
2.1 Zika Virus Testing Industry Trends
2.2 Zika Virus Testing Industry Drivers
2.3 Zika Virus Testing Industry Opportunities and Challenges
2.4 Zika Virus Testing Industry Restraints
3 Global Growth Perspective
3.1 Global Zika Virus Testing Market Perspective (2019-2030)
3.2 Global Zika Virus Testing Growth Trends by Region
3.2.1 Global Zika Virus Testing Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Zika Virus Testing Market Size by Region (2019-2024)
3.2.3 Global Zika Virus Testing Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Zika Virus Testing Revenue by Players
4.1.1 Global Zika Virus Testing Revenue by Players (2019-2024)
4.1.2 Global Zika Virus Testing Revenue Market Share by Players (2019-2024)
4.1.3 Global Zika Virus Testing Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Zika Virus Testing Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Zika Virus Testing Key Players Headquarters & Area Served
4.4 Global Zika Virus Testing Players, Product Type & Application
4.5 Global Zika Virus Testing Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Zika Virus Testing Market CR5 and HHI
4.6.2 Global Top 5 and 10 Zika Virus Testing Players Market Share by Revenue in 2023
4.6.3 2023 Zika Virus Testing Tier 1, Tier 2, and Tier 3
5 Zika Virus Testing Market Size by Type
5.1 Global Zika Virus Testing Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Zika Virus Testing Revenue by Type (2019-2030)
5.3 Global Zika Virus Testing Revenue Market Share by Type (2019-2030)
6 Zika Virus Testing Market Size by Application
6.1 Global Zika Virus Testing Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Zika Virus Testing Revenue by Application (2019-2030)
6.3 Global Zika Virus Testing Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Chembio
7.1.1 Chembio Comapny Information
7.1.2 Chembio Business Overview
7.1.3 Chembio Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.1.4 Chembio Zika Virus Testing Product Portfolio
7.1.5 Chembio Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Comapny Information
7.2.2 Quest Diagnostics Business Overview
7.2.3 Quest Diagnostics Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
7.2.5 Quest Diagnostics Recent Developments
7.3 ARUP Laboratories
7.3.1 ARUP Laboratories Comapny Information
7.3.2 ARUP Laboratories Business Overview
7.3.3 ARUP Laboratories Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
7.3.5 ARUP Laboratories Recent Developments
7.4 Luminex
7.4.1 Luminex Comapny Information
7.4.2 Luminex Business Overview
7.4.3 Luminex Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.4.4 Luminex Zika Virus Testing Product Portfolio
7.4.5 Luminex Recent Developments
7.5 Simens
7.5.1 Simens Comapny Information
7.5.2 Simens Business Overview
7.5.3 Simens Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.5.4 Simens Zika Virus Testing Product Portfolio
7.5.5 Simens Recent Developments
7.6 Abbott Molecular
7.6.1 Abbott Molecular Comapny Information
7.6.2 Abbott Molecular Business Overview
7.6.3 Abbott Molecular Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
7.6.5 Abbott Molecular Recent Developments
7.7 Hologic
7.7.1 Hologic Comapny Information
7.7.2 Hologic Business Overview
7.7.3 Hologic Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.7.4 Hologic Zika Virus Testing Product Portfolio
7.7.5 Hologic Recent Developments
7.8 ELITech Molecular Diagnostics
7.8.1 ELITech Molecular Diagnostics Comapny Information
7.8.2 ELITech Molecular Diagnostics Business Overview
7.8.3 ELITech Molecular Diagnostics Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
7.8.5 ELITech Molecular Diagnostics Recent Developments
7.9 EUROIMMUN US
7.9.1 EUROIMMUN US Comapny Information
7.9.2 EUROIMMUN US Business Overview
7.9.3 EUROIMMUN US Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
7.9.5 EUROIMMUN US Recent Developments
7.10 Creative Diagnostics
7.10.1 Creative Diagnostics Comapny Information
7.10.2 Creative Diagnostics Business Overview
7.10.3 Creative Diagnostics Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
7.10.5 Creative Diagnostics Recent Developments
7.11 Vela Diagnostics
7.11.1 Vela Diagnostics Comapny Information
7.11.2 Vela Diagnostics Business Overview
7.11.3 Vela Diagnostics Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
7.11.5 Vela Diagnostics Recent Developments
7.12 InBios International
7.12.1 InBios International Comapny Information
7.12.2 InBios International Business Overview
7.12.3 InBios International Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.12.4 InBios International Zika Virus Testing Product Portfolio
7.12.5 InBios International Recent Developments
7.13 Primerdesign
7.13.1 Primerdesign Comapny Information
7.13.2 Primerdesign Business Overview
7.13.3 Primerdesign Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.13.4 Primerdesign Zika Virus Testing Product Portfolio
7.13.5 Primerdesign Recent Developments
7.14 Altona Diagnostics
7.14.1 Altona Diagnostics Comapny Information
7.14.2 Altona Diagnostics Business Overview
7.14.3 Altona Diagnostics Zika Virus Testing Revenue and Gross Margin (2019-2024)
7.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
7.14.5 Altona Diagnostics Recent Developments
8 North America
8.1 North America Zika Virus Testing Revenue (2019-2030)
8.2 North America Zika Virus Testing Revenue by Type (2019-2030)
8.2.1 North America Zika Virus Testing Revenue by Type (2019-2024)
8.2.2 North America Zika Virus Testing Revenue by Type (2025-2030)
8.3 North America Zika Virus Testing Revenue Share by Type (2019-2030)
8.4 North America Zika Virus Testing Revenue by Application (2019-2030)
8.4.1 North America Zika Virus Testing Revenue by Application (2019-2024)
8.4.2 North America Zika Virus Testing Revenue by Application (2025-2030)
8.5 North America Zika Virus Testing Revenue Share by Application (2019-2030)
8.6 North America Zika Virus Testing Revenue by Country
8.6.1 North America Zika Virus Testing Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Zika Virus Testing Revenue by Country (2019-2024)
8.6.3 North America Zika Virus Testing Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Zika Virus Testing Revenue (2019-2030)
9.2 Europe Zika Virus Testing Revenue by Type (2019-2030)
9.2.1 Europe Zika Virus Testing Revenue by Type (2019-2024)
9.2.2 Europe Zika Virus Testing Revenue by Type (2025-2030)
9.3 Europe Zika Virus Testing Revenue Share by Type (2019-2030)
9.4 Europe Zika Virus Testing Revenue by Application (2019-2030)
9.4.1 Europe Zika Virus Testing Revenue by Application (2019-2024)
9.4.2 Europe Zika Virus Testing Revenue by Application (2025-2030)
9.5 Europe Zika Virus Testing Revenue Share by Application (2019-2030)
9.6 Europe Zika Virus Testing Revenue by Country
9.6.1 Europe Zika Virus Testing Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Zika Virus Testing Revenue by Country (2019-2024)
9.6.3 Europe Zika Virus Testing Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Zika Virus Testing Revenue (2019-2030)
10.2 China Zika Virus Testing Revenue by Type (2019-2030)
10.2.1 China Zika Virus Testing Revenue by Type (2019-2024)
10.2.2 China Zika Virus Testing Revenue by Type (2025-2030)
10.3 China Zika Virus Testing Revenue Share by Type (2019-2030)
10.4 China Zika Virus Testing Revenue by Application (2019-2030)
10.4.1 China Zika Virus Testing Revenue by Application (2019-2024)
10.4.2 China Zika Virus Testing Revenue by Application (2025-2030)
10.5 China Zika Virus Testing Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Zika Virus Testing Revenue (2019-2030)
11.2 Asia Zika Virus Testing Revenue by Type (2019-2030)
11.2.1 Asia Zika Virus Testing Revenue by Type (2019-2024)
11.2.2 Asia Zika Virus Testing Revenue by Type (2025-2030)
11.3 Asia Zika Virus Testing Revenue Share by Type (2019-2030)
11.4 Asia Zika Virus Testing Revenue by Application (2019-2030)
11.4.1 Asia Zika Virus Testing Revenue by Application (2019-2024)
11.4.2 Asia Zika Virus Testing Revenue by Application (2025-2030)
11.5 Asia Zika Virus Testing Revenue Share by Application (2019-2030)
11.6 Asia Zika Virus Testing Revenue by Country
11.6.1 Asia Zika Virus Testing Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Zika Virus Testing Revenue by Country (2019-2024)
11.6.3 Asia Zika Virus Testing Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Zika Virus Testing Revenue (2019-2030)
12.2 MEALA Zika Virus Testing Revenue by Type (2019-2030)
12.2.1 MEALA Zika Virus Testing Revenue by Type (2019-2024)
12.2.2 MEALA Zika Virus Testing Revenue by Type (2025-2030)
12.3 MEALA Zika Virus Testing Revenue Share by Type (2019-2030)
12.4 MEALA Zika Virus Testing Revenue by Application (2019-2030)
12.4.1 MEALA Zika Virus Testing Revenue by Application (2019-2024)
12.4.2 MEALA Zika Virus Testing Revenue by Application (2025-2030)
12.5 MEALA Zika Virus Testing Revenue Share by Application (2019-2030)
12.6 MEALA Zika Virus Testing Revenue by Country
12.6.1 MEALA Zika Virus Testing Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Zika Virus Testing Revenue by Country (2019-2024)
12.6.3 MEALA Zika Virus Testing Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings